Japanese Journal of Pharmacology 1991: Vol 56 Index

11 Pages·1991·1.6 MB·English

AUTHOR INDEX
Abe, H. ‘NMDA induces PKC translocation 287
See Ushio, Y. Evangelista, S. and Maggi, C.A.
Abe, K., Iri, Y., Takayanagi, M. and Saito, H. Sialoadenectomy and capsaicin 377
bFGF’s trophic action and protein kinase 563
Abe, K., Takayanagi, M. and Saito, H. Fujimoto, M.
bFGF and EGF as neurotrophic factors 113 See Mihara, S.
Aisaka, K., Mitani, A., Kitajima, Y., Ohno, T. Fujimura, A., Kajiyama, H., Ohashi, K.
and Ishihara, T. and Ebihara, A.
Pressor effect of L-NMMA in rats 245 Chronopharmacology of S-8666 43
Aizu, E. Fujimura, A., Kajiyama, H., Shiga, T., Ohashi, K.
See Nakadate, T. and Ebihara, A.
Akahane, K. Chronopharmacology of nitrendipine 237
See Saegusa, K. Fujimura, A., Ohashi, K. and Ebihara, A.
Akimoto, T. Chronopharmacology of S-8666 105
See Ichida, S. Li and urinary furosemide excretion 421
Amano, H. Fujisue, T.
See Ito, Hitoshi See Ichida, S.
Amemiya, N. Fujiwara, M.
See Hatta, S. See Ebii, K.
Aoki, S. Fukunaga, R.
See Kurahashi, K. See Ebii, K.
Arai, M. Furukawa, Y.
See Togari, A. See Saegusa, K.
Ariyoshi, S. Furusawa, K.
See Ichida, S. Drug effects on cognitive function in mice 483
Asashi, T.
See Kuribara, H. Gaggi, R. and Gianni, A.M.
Calcium antagonists and brain amines 33
Baba, A. Gianni, A.M.
See Etoh, S. See Gaggi, R.
Baba, S. Goto, A.
See Tsuchihashi, H. See Yoshimoto, R.
Goto, Shinichiro, Egashira, T. and Yamanaka, Y.
Chiba, S. Serotonin uptake inhibitors in CSF 297
See Saegusa, K. Goto, Shoichi
See Nagai, H.
Dohi, T.
See Yoshimura, Y. Handa, J.
Dohmoto, H. See Takakura, S.
See Yoshimoto, R. Haniuda, M.
See Saegusa, K.
Ebihara, A. Harada, M.
See Fujimura, A. See Takayanagi, I.
Ebii, K., Fukunaga, R., Taniguchi, T., Fujiwara, M.., Hashida, R.
Nakayama, S., Saitoh, Yuichi and Kimura, Y. See Saeki, T.
Carteolol and £-receptors in SHR heart 505 Hashimoto, K.
Egashira, T. See Sugiyama, A.
See Goto, Shinichiro Hashimoto, M.
Eizawa, H. See Yamada, M.
See Hiki, K. Hata, T., Itoh, E. and Kawabata, A.
Epand, R.M. Serotonin in stressed rats 101
See Nakamuta, H. Hata, T., Kawabata, A. and Itoh, E.
Etoh, S., Baba, A. and Iwata, H. SART stress and hemostatic system 403
Hatakeyama, K., Yano, S. and Watanabe, K. See Morishita, S.
PAF and gastric lesions 271 Ito, M.
Hatta, S., Amemiya, N. and Ohshika, H. See Hattori, T.
Galactosamine and adenylate cyclase activity 385 Re, Y.
Hattori, R. See Iwanaga, Y.
See Hiki, K. Itoh, E.
Hattori, T., Ito, M. and Suzuki, Y. See Hata, T.
Effect of TJ-8014 on PAN-nephrosis 465 Itoh, Z.
Hibi, M. See Iwanaga, Y.
See Yamamoto, A. Itokazu, Y.
Hiki, K., Yui, Y., Hattori, R., Eizawa, H., See Nakamuta, H.
Kosuga, K. and Kawai, C. Iwama, T.
Cytosolic and membrane-bound NO synthase 217 See Yamamoto, A.
Hironaka, M. Iwamoto, M.
See Togari, A. See Kurahashi, K.
Hisajima, H., Miyagawa, T., Saito, H. Iwanaga, Y., Miyashita, N., Mizutani, F.,
and Nishiyama, N. Morikawa, K., Kato, Hideo, Ito, Y. and Itoh, Z.
Neurotrophic effects of human aFGF 495 HSR-803 on gastrointestinal propulsion 261
Hombhanje, F. Iwasaki, K.
Sulphadimidine dosage on acetylator phenotyping See Nakazawa, M.
531 Iwata, H.
See Etoh, S.
Ichida, S., Ariyoshi, S., Fujisue, T., Wada, T.
and Akimoto, T. Jiang, H.
Effects of calcium agonists on rat uterus 397 See Nakadate, T.
Imai, S.
See Nakazawa, M. Kaburagi, T.
Imai, Y. See Shimizu, K.
See Yonehara, N. Kajiyama, H.
Inaba, N., Inazu, N., Kogo, H. and Satoh, Tetsuo See Fujimura, A.
Antiestrogen and aldo-keto reductase 61 Kamegaya, Y.
Inami, K. See Nakadate, T.
See Yoshida, Y. Kamei, J., Tanihara, H. and Kasuya, Y.
Inazu, N. Antitussive tolerance and x-opioid receptors 557
See Inaba, N. Kamei, K., Tsuchida, S., Taguchi, K.
Inoki, R. and Nishikibe, M.
See Yonehara, N. Effect of NB-818 on neuronal death 279
Inoue, O. Kaneto, H.
See Takase, H. See Takahashi, M.
in, Y. Kashima, K.
See Abe, K. See Kato, M.
Ishihara, M. Kasuya, Y.
See Nakadate, T. See Kamei, J.
Ishihara, T. Kataoka, K.
See Aisaka, K. See Kato, M.
Ishikawa, M., Takayanagi, Y. and Sasaki, K. Kato, Hideo
Exacerbation of DOX toxicity by CPZ 221 See Iwanaga, Y.
Ishikawa, N. Kato, Hitoshi
See Sakakibara, H. See Takata, Y.
Ishitani, R. Kato, M., Ohkuma, S., Kataoka, K., Kashima, K.,
See Saito, M. Mukainaka, T. and Kuriyama, K.
Ito, Hiroko Amylase release from pancreatic acini 311
See Ito, Hitoshi Kato, R.
Ito, Hitoshi, Ito, Hiroko, Amano, H. and Noda, H. See Nakadate, T.
Antitumor effect of cepharanthin 195 Kawabata, A.
Ito, C. See Hata, T.
Kawaguchi, A. Kusama, T., Murakoshi, Y. and Murakami, H.
See Kurahashi, K. Withdrawal response of hippocampal slices 213
Kawaguchi, M.
See Sawaki, K. Maggi, C.A.
Kawai, C. See Evangelista, S.
See Hiki, K. Mano, F.
Kawamura, Makoto, Yamazaki, S., Tobe, A., See Tsuchihashi, H.
Watanabe, S. and Takeuchi, T. Maruyama, K.
Effects of MCI-727 on plasma secretin 513 See Tsuchihashi, H.
Kawamura, Masahiro, Matsui, T., Niitsu, A., Masuda, Y. and Yamamori, Y.
Kondo, T., Ohno, Y. and Nakamichi, N. CBrCl3 hepatotoxicity in isolated livers 143
Purinoceptor in adrenocortical cell 543 Histology of lipid peroxidation 133
Kawanishi, M. Matsui, T.
See Sakakibara, H. See Kawamura, Masahiro
Kimura, I. Matsumoto, K.
See Naitoh, T. See Ohta, H.
See Nojima, H. Matsumoto, S.
Kimura, M. See Togari, A.
See Naitoh, T. Mihara, S. and Fujimoto, M.
See Nojima, H. Effect of S-312 on 1,4-DHP binding sites 249
Kimura, Y. Mitani, A.
See Ebii, K. See Aisaka, K.
Kinatni, J. Miyagawa, T.
See Tsuchihashi, H. See Hisajima, H.
Kitagaki, K. Miyashita, N.
See Nagai, H. See Iwanaga, Y.
Kitajima, Y. Mizutani, F.
See’ Aisaka, K. See Iwanaga, Y.
Kitamura, Y., Ohnuki, T. and Nomura, Y. Mori, H.
Bifemelane on mACh-R in SAM brain 231 See Yoshida, Y.
Kiuchi, Y. Mori, J.
See Yamada, M. See Takakura, S.
Kobayashi, S. Morikawa, K.
See Naitoh, T. See Iwanaga, Y.
Koda, A. Morisaki, N.
See Nagai, H. See Saeki, T.
See Yoshida, Y. Morishita, S., Shoji, M., Oguni, Y., Ito, C.,
Kogo, H. Noguchi, K. and Sakanashi, M.
See Inaba, N. Experimental congestive heart failure 427
Koida, M. Motomura, S.
See Nakamuta, H. See Sugiyama, A.
Koike, K. Mukainaka, T.
See Takayanagi, I. See Kato, M.
Kondo, T. Murakami, H.
See Kawamura, Masahiro See Kusama, T.
Kosuga, K. Murakoshi, Y.
See Hiki, K. See Kusama, T.
Krieglstein, J.
See Rischke, R. Nagai, H., Kitagaki, K., Goto, Shoichi, Suda, H.
Kurahashi, K., Usui, H., Iwamoto, M., Aoki, S., and Koda, A.
Kawaguchi, A. and Oikawa, H. K* channel opener and allergic reaction 13
Artery reinnervated by cholinergic fiber 117 Nagata, M. and Osumi, Y.
Kuribara, H., Asashi, T. and Tadokoro, S. Nicotine and gastric motility 539
Interaction between opioids and ethanol 457 Nagatomo, T.
Kuriyama, K. See Tsuchihashi, H.
See Kato, M. Naitoh, T., Kobayashi, S., Kimura, I.
and Kimura, M. See Takayanagi, I.
[Ca?*];-regulated glucose uptake by insulin 241 Oikawa, H.
Nakadate, T., Yamamoto, S., Kamegaya, Y., See Kurahashi, K.
Ishihara, M., Aizu, E., Jiang, H. and Kato, R. Orlowski, R.C.
ODC induction and protein kinase C 203 See Nakamuta, H.
Nakajyo, S. Osumi, Y.
See Shimizu, K. See Nagata, M.
Nakamichi, N. Ouchi, K.
See Kawamura, Masahiro See Sawaki, K.
Nakamuta, H., Itokazu, Y., Koida, M., Ozawa, J.
Orlowski, R.C. and Epand, R.M. See Takata, Y.
hCT sensitive binding sites 551
Nakayama, S. Rischke, R. and Krieglstein, J.
See Ebii, K. Neuroprotective effects of vinpocetine 349
Nakazawa, M., Sawanobori, T., Iwasaki, K.
and Imai, S. Saegusa, K., Furukawa, Y., Akahane, K..,
Benazeprilat and acute heart failure 369 Haniuda, M. and Chiba, S.
Ni, X.-H. Eperisone on the heart 187
See Ohta, H. Saeki, T., Ohtsuka, I., Hashida, R., Shiojiri, H.,
Niitsu, A. Yamatsu, I., Morisaki, N. and Saito, Yasushi
See Kawamura, Masahiro Antiatheromatous effect of E5050 159
Nishikibe, M. Saito, H.
See Kamei, K. See Abe, K.
Nishiyama, N. See Hisajima, H.
See Hisajima, H. Saito, K.
Noda, H. See Takayanagi, I.
See Ito, Hitoshi Saito, M., Serikyaku, S. and Ishitani, R.
Noguchi, K. Lipids in tryptamine binding sites 413
See Morishita, S. Saito, Yasushi
Nojima, H., Kimura, I. and Kimura, M. See Saeki, T.
Ca**-dependence of ACh-contractures 109 Saito, Yuji
Nomura, Y. See Takase, H.
See Kitamura, Y. Saitoh, Yuichi
See Ebii, K.
Oguchi, K. Sakakibara, H., Taki, K., Kawanishi, M.,
See Yamada, M. Shimada, Y. and Ishikawa, N.
Oguni, Y. Lung vascular permeability 391
See Morishita, S. Sakanashi, M.
Ohashi, K. See Morishita, S.
See Fujimura, A. Sakashita, M.
Ohkuma, S. See Yamamoto, A.
See Kato, M. Sasaki, K.
Ohno, T. See Ishikawa, M.
See Aisaka, K. Sato, Toshihiro
Ohno, Y. See Sawaki, K.
See Kawamura, Masahiro Satoh, H.
Ohnuki, T. See Takakura, S.
See Kitamura, Y. Satoh, M.
Ohshika, H. See Takayanagi, I.
See Hatta, S. Satoh, Tetsuo
Ohta, H., Ni, X.-H., Matsumoto, K. See Inaba, N.
and Watanabe, H. Sawaki, K., Ouchi, K., Sato, Toshihiro
Physostigmine and working memory in rats 303 and Kawaguchi, M.
Ohtsuka, I. Local anesthetic convulsions and GABA 327
See Saeki, T. Sawanobori, T.
Ohtsuki, H. See Nakazawa, M.
Serikyaku, S. and Satoh, M.
See Saito, M. PrBCM-sensitive cholinoceptors 151
Shiga, T. Takayanagi, M.
See Fujimura, A. See Abe, K.
Shiino, A. Takayanagi, Y.
See Takakura, S. See Ishikawa, M.
Shikada, K. Takeuchi, T.
See Yamamoto, A. See Kawamura, Makoto
Shimada, A. and Yanagita, T. Taki, K.
Barbital tolerance and physical dependence 71 See Sakakibara, H.
Shimada, Y. Tanaka, Sakuya
See Sakakibara, H. See Yamamoto, A.
Shimizu, K., Kaburagi, T., Nakajyo, S. Tanaka, Shoukichi
and Urakawa, N. See Yoshimura, Y.
Muscle tension and glucose utility 53 Taniguchi, T.
Shinoda, H. See Ebii, K.
See Togari, A. Tanihara, H.
Shiojiri, H. See Kamei, J.
See Saeki, T. Tobe, A.
Shoji, M. See Kawamura, Makoto
See Morishita, S. Togari, A., Arai, M., Hironaka, M., Matsumoto, S.
Silva, W.I. and Shinoda, H.
G, and Gg subunits in coated vesicles 97 HEBP on experimental osteoporosis 177
G, subunits in coated vesicles 93 Tsuchida, S.
Suda, H. See Kamei, K.
See Nagai, H. Tsuchihashi, H., Maruyama, K., Baba, S., Mano, F.,
Sugiyama, A., Motomura, S. and Hashimoto, K. Kinami, J. and Nagatomo, T.
Cardiovascular effects of NIK-244 1 a,-Adrenoceptor subtypes 523
Susumu, T. Tsujimoto, A.
See Takakura, S. See Yoshimura, Y.
Suzuki, A.
See Takase, H. Uchida, M., Yano, S. and Watanabe, K.
Suzuki, Y. Gastric antral ulcer in rats 475
See Hattori, T. Urakawa, N.
See Shimizu, K.
Tadokoro, S. Ushio, Y. and Abe, H.
See Kuribara, H. Increase in yeast phagocytosis by saikosaponin-d
Taguchi, K. 167
See Kamei, K. Usui, H.
Takada, K. See Kurahashi, K.
See Yoshimura, Y.
Takahashi, M. and Kaneto, H. Wada, T.
Stresses and spinal morphine tolerance 121 See Ichida, S.
Takakura, S., Susumu, T., Satoh, H., Mori, J., Watanabe, H.
Shiino, A. and Handa, J. See Ohta, H.
Brain protection with nilvadipine 547 Watanabe, K.
Takase, H., Inoue, O., Saito, Yuji, Yumioka, E. See Hatakeyama, K.
and Suzuki, A. See Uchida, M.
Protective property of Oren-gedoku-to 433 Watanabe, S.
Takata, Y., Ozawa, J. and Kato, Hitoshi See Kawamura, Makoto
NE release and low Ca?* + TEA medium 535
Protein kinase C and norepinephrine release 337 Yamada, K.
Takayanagi, I., Harada, M. and Koike, K. See Yoshimoto, R.
PrBCM-sensitive and -resistant muscarinic receptors Yamada, M., Kiuchi, Y., Hashimoto, M., Oguchi, K.
23 and Yasuhara, H.
Takayanagi, I., Ohtsuki, H., Saito, K., Koike, K. PEA treated rats after withdrawal 127
Yamamori, Y. See Uchida, M.
See Masuda, Y. Yasuhara, H.
Yamamoto, A., Shikada, K., Iwama, T., See Yamada, M.
Sakashita, M., Hibi, M. and Tanaka, Sakuya Yonehara, N., Imai, Y. and Inoki, R.
NZ-107 modulates tracheal response 79 Heat stimulation and neuropeptides 381
Yamamoto, S. Yoshida, Y., Mori, H., Inami, K. and Koda, A.
See Nakadate, T. Active principle of prostate extract 357, 441
Yamanaka, Y. Yoshimoto, R., Dohmoto, H., Yamada, K.
See Goto, Shinichiro and Goto, A.
Yamatsu, I. Inhibition of Ca influx by cinaldipine 225
See Saeki, T. Yoshimura, Y., Dohi, T., Tanaka, Shoukichi,
Yamazaki, S. Takada, K. and Tsujimoto, A.
See Kawamura, Makoto Brain catecholamines and lidocaine convulsions 85
Yanagita, T. Vou x;
See Shimada, A. See Hiki, K.
Yano, S. Yumioka, E.
See Hatakeyama, K. See Takase, H.
SUBJECT INDEX
A431 cells 203 Ca’?*-dependence 109
Acetylator phenotyping 531 Calcitonin (human) 551
Acidic fibroblast growth factor 495 Calcitonin gene-related peptide 381
Acoustic stimulation 127 Calcitonin receptor subtype 551
Active metabolite 43 Calcium agonists 397
Adenosine 79 Calcium influx 225
Adenylate cyclase 385 Capsaicin 377
ADP-Fe** 133 Cardiac 8-adrenoceptor 505
a,-Adrenoceptors 523 Carteolol 505
Aged rat 43, 303 Castrated rat 441
Aldo-keto reductase 61 Catecholamine 85
Allergic reaction 13 Cell culture 495
Ambulatory activity (mouse) 457 Cell growth 203
y-Aminobutyric acid 327 Cepharanthin 195
Ammonia 475 Cerebellar neuron survival 113
Amylase release 311 Cerebral ischemia 349, 547
Angiotensin converting enzyme inhibitor 369 Cerebrospinal fluid (human) 297
Anti-GBM nephritis 465 Chlorpromazine 221
Anti-prostatic hypertrophy 441 Cholesterol-fed rabbits 159
Anti-ulcer agent 513 Cholinergic partial agonist 151
Antiestrogen 61 Chronopharmacology 43, 105, 237
Antinociception 121 Chronotropism 1
Antitussive effect 557 Clathrin coated vesicles 93, 97
Antral ulcer 475 Compression-type contracture 109
Aortic smooth muscle cells (rat) 249 Contraction 337
Arachidonate metabolism 271 Convulsion 85, 327
Aspirin 475 Coronary embolization 369
Atherosclerosis 159 Cortical evoked potential 71
ATP 543 Cytosolic 217
Atrium (isolated dog) 187 Cytosolic Ca2* 151, 249
Autoradiography 551
Delayed nonmatching to position task 303
Barbital 71 Dentin 177
Basic fibroblast growth factor 113, 563 2-Deoxy-D-glucose 475
Basilar blood vessels (porcine) 249 Depolarization 337
Behavior 127 Diaphragm muscle 241
Benazeprilat 369 Diazepam 457
Bifemelane hydrochloride 231 Digoxin 427
Biogenic amines 33 1,4-Dihydropyridine binding sites 249
Blood coagulation 403 Diuretic effect 237
Blood pressure 245 Dopaminergic system 33
Bone 177 Dorsal motor nucleus of vagus 539
Brain (mouse) 85 Dosage 531
Brain (rat) 523 Doxorubicin (toxicity) 221
Brain amine levels 127 Dromotropism 1
Brain sections 33 Drug effects 483
Bromotrichlomomethane hepatotoxicity 143 Drug interaction 421
Bronchoconstriction 13
t-Butyl hydroperoxide 133 E5050 (N-{3-[4’-(2” ,6’-dimethylheptyl)phenyl]-
butanoyl}ethanolamine) 159
“Ca uptake 397 Endogenous substances 297
Ca?* channel 535 Eperisone 187
Ca?* channel blocker 33, 547 Epidermal growth factor 113
Ethanol 457 Lipid peroxidation 133, 143
Euglobulin clot lysis time 403 Lithium 421
Experimental asthma 13 Local anesthetic 327
Experimental congestive heart failure 427 Local cerebral blood flow 349
Loop diuretic 43, 105
Fe receptor 167 Lung metastasis 195
Fibrinogen 403 Lungs 391
Fibrinolysis 403 Luteinizing hormone-releasing hormone (LH-RH)
Fibrous plaque 159 61
Flecainide 1
Footshock stress 121 Macrophages 167
FRC-8653 (2-methoxyethyl(E)-3-phenyl-2-propen-1- MCI-727 ((Z)-2-(4-methylpiperazin-1-yl)-1-[4-(2-
yl( + )-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)- phenyl-ethyl)phenyl]-ethanone oxime hydrochloride
pyridine-3,5-dicarboxylate) 225 monohydrate 513
Fuchsin staining 133 Membrane-bound 217
Full agonist 23 Memory 483
Furosemide 421 N-Methyl-D-aspartate 287
Mineralization 177
Galactosamine 385 Morphine 121
Gastric damage 271 Muscarinic receptor 187, 231, 311
Gastric emptying 261
Gastric motility 539 Na‘ channel 535
Gastric mucosal protection 433 Naloxone 213
Gastric ulcers 377 NB-818 (isopropyl methyl 2-carbamoyloxymethyl-6-
Gastrin 513 methyl-4-(2,3-dichlorophenyl)1 ,4-dihydropyridine-
Gerbil 279 3,5-dicarboxylate) 279
Glutamic acid 327 Necrosis 143
GTP-binding protein 385 Neurokinin A 381
GTP-binding proteins alpha subunits 93, 97 Neuron 495
GTP-binding proteins beta subunits 97 Neuronal damage 349
Neuronal death 279
Heart failure 369 Neuronal survival 563
HEBP (1-hydroxyethylidene-1 ,1-bisphosphonate) Neurotrophic factor 495
177 N°-monomethyl-L-arginine (L-NMMA) 245
High K* ,Na* -deficient solution 53 Nicotine 539
Hippocampal slice 213 Nicotinic receptor 187
Hippocampus 279, 349 NIK-244 (Ethacizin) (2-(ethoxycarbonylamino)-10-(3-
5-HT uptake 297 (diethylamino)propionyl) phenothiazine hydrochlo-
Hydrochloric acid 475 ride) 1
Nilvadipine 547
IgE antibody 13 Nitrendipine 237
Ileum (guinea pig) 53 Nitric oxide 245
Imipramine binding 297 Nitric oxide synthase 217
Implantation 117 Non-matching to sample 483
Inotropism 1 Norepinephrine release 337, 535
Insulin-stimulated glucose uptake 241 NZ-107 (4-bromo-5-(3-ethoxy-4-methoxybenzyl-
Intracellular Ca** 241 amino)-3(2H)-pyridazinone) 79
Intrinsic sympathomimetic activity 505
Opioid analgesics 457
Jackknife-type contracture 109 x-Opioid receptors 557
Japanese herbal medicine 465 Oren-gedoku-to (OGT) 433
Ornithine decarboxylase 203
K* channel opener 13 Ovariectomy 177
Ovary (rat) 61
Learning 483 Ovulation 61
Lidocaine 85 Oxidized flavoproteins (FPox) 53
Oxygen consumption 369 Saikosaponin-d 167
Saphenous vein (canine) 337, 535
Pancreatic acini (isolated) 311 Scavengers 465
Pancreatic secretion 513 Secretin 513
Papua New Guineans 531 Senescence-accelerated mouse 231
Paroxetine binding 297 Serotonergic system 33
Partial agonist 23 Serotonin 101
Pentobarbital 457 Single skeletal muscle cell 109
Perfused liver 133, 143 Small intestinal transit 261
Phagocytosis 167 Smooth muscle cell 159
&-Phenylethylamine 127 Spinal cord 327
Phosphatidylserine 413 Spinal tolerance 121
Phospholipase A, 413 Spleen (rat) 523
Physical dependence 71 Spontaneously hypertensive rats 505
Physostigmine 303 Steroidogenesis 543
Platelet activating factor 271 Stress 101, 403
°H-Prazosin 523 Subclassification 523
Preganglionic trunk 117 Substance P 381
Propylbenzilylcholine mustard (PrBCM) 23 Sulfhydryl compounds 433
Propylbenzilylcholine mustard (PrBCM)-resistant Sulphadimidine 531
cholinoceptors 23, 151 Sympathetic nerve stimulation 391
Propylbenzilylcholine mustard (PrBCM)-sensitive Synaptoneurosome 287
cholinoceptors 23, 151
Prostaglandin 79, 271 Temperature-sensitive high-affinity binding sites 413
Prostate extract 357, 441 Tension 53
Prostate extract (purified) 357, 441 Tension development 151
Prostatic hypertrophy 357 Testosterone 441
Protein kinase 563 Testosterone uptake 357
Protein kinase C 203, 287, 337 Toad venom 427
Psychological stress 121 Tolerance 71, 557
Purinoceptor 543 Tracheal response 79
Puromycin aminonucleoside (PAN) 465 Translocation 287
Pyridine nucleotides (PNred) 53 Tryptamine 413
Tubular secretion 421
Reactive oxygen species 465
Rebound phenomena 505 Uterine segments (rat) 397
Reinnervation 117
Repeated cold stress 101 Vascular permeability 271, 391
Retina 495 Vinpocetine 349
Reverse tolerance 127
Water-immersion stress 377
S-312 (methyl 4,7-dihydro-3-isobutyl-6-methyl-4-(3- Withdrawal response 213
nitrophenyl)thieno[2,3-b]pyridine-5-carb oxylate) Working memory 303
249
S-8666 (6,7-dichloro-5-(N ,N-dimethylsulfamoyl)-2,3- Yeasts 167
dihydro-2-benzofuran carboxylic acid) 43, 105